From: The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience
Variable
F0-F1
F2-F4
Total
p value
PR
CI 95%
SIBO, n (%)
 Yes
26 (72.2)
10 (27.8)
36 (100)
0.371
1.514
0.608–3.772
 No
63 (79.7)
16 (20.3)
79 (100)